New Breast Cancer Results Illustrate Promise and Potential of I-SPY 2

In an innovative clinical trial led by UC San Francisco, the experimental drug neratinib along with standard chemotherapy was found to be a beneficial treatment for some women with newly diagnosed, high-risk breast cancer.

Source: UCSF Medical Center - April 8, 2014 Category: Universities & Medical Training Authors: webservices at ucsfhealth.org Source Type: news